In Search of Slowness
Systematic empirical research casts into doubt claims that rulemaking procedures have slowed down the regulatory process.
Do Expert Agencies Outperform Generalist Judges?
Empirical evidence suggests that expert agencies perform no better than courts.
Coalition Calls for Increased Oversight of Synthetic Biology
Advocacy groups say current regulation of synthetic biology offers inadequate public protection.
Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges
Challenges to branded drugs from generic firms have benefits and costs.
Supreme Court and PTO Produce New Rules on “Laws of Nature” Patents
After the Mayo decision, Patent and Trademark Office issues guiding memorandum.
Will Obama be Damaged by New Administrative Scandals?
Recent scandals will likely reinforce existing predispositions more than move the political needle.
Member of Congress Documents “Loophole” for Medical Device Approval
Advocacy groups join Rep. Markey in calling for reform of FDA review process.
Feds Claim Unlawful “Conspiracy” Inflated Prices of E-books
Antitrust lawsuit alleges Apple and five publishers conspired to eliminate competition.
WTO Creates Roadblock to Administration’s Anti-Smoking Initiative
U.S. prohibition of flavored cigarettes violates international trade agreement.
EPA to Regulate Carbon Emissions from New Power Plants
Proposed rule would impose the first greenhouse gas standards on new facilities.
A Confluence of Concerns with the Accumulation of Regulatory Regimens
Requiring agencies to consider the cumulative costs of their regulation has its own cumulative costs.